These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 37480469)

  • 21. Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology.
    Readhead B; Haure-Mirande JV; Zhang B; Haroutunian V; Gandy S; Schadt EE; Dudley JT; Ehrlich ME
    Mol Psychiatry; 2016 Aug; 21(8):1099-111. PubMed ID: 26552589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of App knock-in mice reveals deletion mutations protective against Alzheimer's disease-like pathology.
    Nagata K; Takahashi M; Matsuba Y; Okuyama-Uchimura F; Sato K; Hashimoto S; Saito T; Saido TC
    Nat Commun; 2018 May; 9(1):1800. PubMed ID: 29728560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.
    Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S
    Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic mouse models of Alzheimer's disease.
    Elder GA; Gama Sosa MA; De Gasperi R
    Mt Sinai J Med; 2010; 77(1):69-81. PubMed ID: 20101721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress toward valid transgenic mouse models for Alzheimer's disease.
    Guénette SY; Tanzi RE
    Neurobiol Aging; 1999; 20(2):201-11. PubMed ID: 10537029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions.
    Kokjohn TA; Roher AE
    Alzheimers Dement; 2009 Jul; 5(4):340-7. PubMed ID: 19560104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
    J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer's disease.
    Li W; Pang Y; Wang Y; Mei F; Guo M; Wei Y; Li X; Qin W; Wang W; Jia L; Jia J
    BMC Med; 2023 Jun; 21(1):223. PubMed ID: 37365538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular and molecular biology of Alzheimer's disease and animal models.
    Price DL; Sisodia SS
    Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
    Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
    Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease.
    Kukreja L; Kujoth GC; Prolla TA; Van Leuven F; Vassar R
    Mol Neurodegener; 2014 May; 9():16. PubMed ID: 24885175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Martínez-Iglesias O; Naidoo V; Carrera I; Cacabelos R
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic animal models for Alzheimer's disease.
    Fukuchi K; Ogburn CE; Smith AC; Kunkel DD; Furlong CE; Deeb SS; Nochlin D; Sumi SM; Martin GM
    Ann N Y Acad Sci; 1993 Sep; 695():217-23. PubMed ID: 8239285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APP mouse models for Alzheimer's disease preclinical studies.
    Sasaguri H; Nilsson P; Hashimoto S; Nagata K; Saito T; De Strooper B; Hardy J; Vassar R; Winblad B; Saido TC
    EMBO J; 2017 Sep; 36(17):2473-2487. PubMed ID: 28768718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crucial role of calbindin-D28k in the pathogenesis of Alzheimer's disease mouse model.
    Kook SY; Jeong H; Kang MJ; Park R; Shin HJ; Han SH; Son SM; Song H; Baik SH; Moon M; Yi EC; Hwang D; Mook-Jung I
    Cell Death Differ; 2014 Oct; 21(10):1575-87. PubMed ID: 24853300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dickkopf 3 (Dkk3) Improves Amyloid-β Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.
    Zhang L; Sun C; Jin Y; Gao K; Shi X; Qiu W; Ma C; Zhang L
    J Alzheimers Dis; 2017; 60(2):733-746. PubMed ID: 28922151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide.
    Sato K; Watamura N; Fujioka R; Mihira N; Sekiguchi M; Nagata K; Ohshima T; Saito T; Saido TC; Sasaguri H
    J Biol Chem; 2021 Sep; 297(3):101004. PubMed ID: 34329683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.